Reckitt Benckiser Group (LON:RB) Given New GBX 6,100 Price Target at Goldman Sachs Group
Reckitt Benckiser Group (LON:RB) had its target price reduced by Goldman Sachs Group from GBX 6,300 ($82.87) to GBX 6,100 ($80.24) in a research note released on Wednesday morning, Borsen Zeitung reports. They currently have a neutral rating on the stock.
RB has been the topic of a number of other research reports. DZ Bank cut their price objective on shares of Reckitt Benckiser Group from GBX 6,500 ($85.50) to GBX 6,000 ($78.93) and set a hold rating on the stock in a research report on Thursday, October 31st. Deutsche Bank cut their price objective on shares of Reckitt Benckiser Group from GBX 7,500 ($98.66) to GBX 7,200 ($94.71) and set a buy rating on the stock in a research report on Wednesday, January 29th. Barclays boosted their price objective on shares of Reckitt Benckiser Group from GBX 7,000 ($92.08) to GBX 7,400 ($97.34) and gave the stock an overweight rating in a research report on Thursday, January 30th. Jefferies Financial Group reissued a sell rating and issued a GBX 5,000 ($65.77) price objective on shares of Reckitt Benckiser Group in a research report on Friday, November 15th. Finally, Societe Generale cut their price objective on shares of Reckitt Benckiser Group from GBX 5,500 ($72.35) to GBX 5,300 ($69.72) and set a sell rating on the stock in a research report on Tuesday, November 26th. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of GBX 6,598.24 ($86.80).
Shares of RB stock traded down GBX 258 ($3.39) during trading on Wednesday, reaching GBX 5,841 ($76.84). The company’s stock had a trading volume of 3,190,509 shares, compared to its average volume of 1,720,000. The business has a fifty day moving average price of GBX 6,265.50 and a 200-day moving average price of GBX 6,142.57. The company has a quick ratio of 0.43, a current ratio of 0.59 and a debt-to-equity ratio of 85.08. The company has a market cap of $41.44 billion and a price-to-earnings ratio of 29.32. Reckitt Benckiser Group has a one year low of GBX 5,510 ($72.48) and a one year high of GBX 8,191.30 ($107.75).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Recommended Story: How much money do you need to begin day trading?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.